• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Lithium for Brain Health?
Research Update

Lithium for Brain Health?

January 31, 2023
Kathryn Kieran, MSN, PMHNP-BC
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kathryn Kieran, MSN, PMHNP-BC. Ms. Kieran has no financial relationships with companies related to this material.

REVIEW OF: Chen S et al, PLoS Medicine 2022;19(3):e1003941

STUDY TYPE: Retrospective cohort study

Low-dose lithium has recently been proposed as a potential treatment for dementia, based on a couple of retrospective studies (Gerhard T et al, Br J Psychiatry 2015;207(1):46–51; Kessing LV et al, Bipolar Disord 2010;12(1):87–94). This newest study looks at evidence that standard doses of lithium might also be helpful in preventing the development of dementia.

The study compared the electronic records of 29,618 adults in the UK age 50 years and older without diagnoses of mild cognitive impairment (MCI) or dementia. The 548 patients exposed to lithium had a greater number of cardiovascular risk factors, including antipsychotic use, central vascular disease, diabetes, hyperlipidemia, hypertension, and smoking. Of those prescribed lithium, 73% had a mania/bipolar affective disorder (BPAD) diagnosis, a known risk factor for dementia, while the remaining lithium-exposed patients were diagnosed with depression.

In the lithium-exposed cohort, 9.7% of patients were diagnosed with dementia, compared to 11.2% of the unexposed cohort. The percentage of patients diagnosed with Alzheimer’s disease was significantly lower in the lithium-exposed cohort (6.8%) compared to the unexposed cohort (8.1%), whereas the percentage of vascular dementia was the same in both cohorts (2.6%). Lithium appeared to lower dementia risk for the group taking lithium for one year or less and the group taking it for more than five years (the smaller cohort of patients taking lithium for two to four years saw no benefits, likely due to a lack of statistical power). Documented serum lithium levels were 0.49–0.80 mEq/L, with a mean of 0.61 mEq/L.

Method of diagnosis, dosing, follow-up, and adherence were highly variable or unknown. Some lithium level data were missing, so patients with supratherapeutic levels may have experienced neurotoxic effects, which can mimic dementia.

Carlat Take

We all want something to offer patients with risk factors for dementia or MCI, without peddling false hope. This study suggests that lithium might delay or prevent Alzheimer’s disease in individuals with BPAD, but the real-world conditions are limited. The variables are too numerous to contain even in this careful analysis. However, it is reasonable to discuss possible advantages of lithium in terms of dementia risk with patients already taking lithium, particularly in patients who stick with lithium long term.

Geriatric Psychiatry Research Update
KEYWORDS Bipolar depression Dementia Lithium
    Kathryn Kieran, MSN, PMHNP-BC

    High-Dose Aspirin and Age Are the Only Convincing Depression Risk Factors in Late Life

    More from this author
    www.thecarlatreport.com
    Issue Date: January 31, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Bipolar Disorder in Older Adults, CGPR, January/February/March 2023
    Mood Stabilizers for Bipolar Disorder in Older Adults: Special Considerations
    New-Onset Bipolar Disorder in Older Adults
    Mania in Older Adults
    Pharmacological Treatment of Bipolar Disorder in Older Adults
    Lithium for Brain Health?
    CME Post-Test, Bipolar Disorder in Older Adults, CGPR, January/February/March 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.